Till startsida
Sahlgrenska Academy Institute of Neuroscience and Physiology
Sitemap
To content Read more about how we use cookies on gu.se

Michael Schöll

Universitetslektor/biträdande

OverviewPublicationsUNDEFINEDUNDEFINEDUNDEFINED

Michael Schöll
Universitetslektor/biträdande
michael.scholl@neuro.gu.se

Postal Address: Sahlgrenska University Hospital, MedTech West, Röda stråket 10B, SE-41345 Gothenburg
Visiting Address: Sahlgrenska University Hospital, MedTech West, Röda stråket 10B , SE-41345 Gothenburg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Michael Schöll

Research areas

Latest publications

Imaging biomarkers in neurodegeneration: current and future practices.
Peter N E Young, Mar Estarellas, Emma Coomans, Meera Srikrishna, Helen Beaumont et al.
Alzheimer's research & therapy, Review article 2020
Review article

Read the full text
on a web page

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies.
Thomas Vogels, Antoine Leuzy, Claudia Cicognola, Nicholas J. Ashton, Tomas Smolek et al.
Biological psychiatry, Journal article 2020
Journal article

Read the full text
on a web page

Relevance of biomarkers across different neurodegenerative.
Alexander J Ehrenberg, Ayesha Khatun, Emma Coomans, Matthew J Betts, Federica Capraro et al.
Alzheimer's research & therapy, Review article 2020
Review article

Read the full text
on a web page

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin Senkevich, Jörg Hanrieder et al.
Alzheimer's research & therapy, Review article 2020
Review article

Read the full text
on a web page

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.
Nicholas J. Ashton, Abdul Hye, Anto P Rajkumar, Antoine Leuzy, Stuart Snowden et al.
Nature Reviews Neurology, Review article 2020
Review article

Read the full text
on a web page

University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019-course organisation.
Ayesha Khatun, Ross W Paterson, Michael Schöll
Alzheimer's research & therapy, Review article 2020
Review article

Read the full text
on a web page

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Thomas Karikari, Tharick A Pascoal, Nicholas J. Ashton, Shorena Janelidze, Andréa Lessa Benedet et al.
The Lancet. Neurology, Journal article 2020
Journal article

Read the full text
on a web page

Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948.
Ruben Smith, Michael Schöll, Antoine Leuzy, Jonas Jögi, Tomas Ohlsson et al.
European journal of nuclear medicine and molecular imaging, Journal article 2020
Journal article

Read the full text
on a web page

Does early cognitive decline require the presence of both tau and amyloid-β?
Michael Schöll, Anne Maass
Brain : a journal of neurology, Journal article 2020
Journal article

Read the full text
on a web page

Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum.
Meenu Rohin Rajan, Matus Sotak, Fredrik Barrenäs, Tong Shen, Kamil Borkowski et al.
Scientific reports, Journal article 2019
Journal article

Read the full text
on a web page

Showing 21 - 30 of 88

2019

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
Nicholas J. Ashton, Antoine Leuzy, Yau Mun Lim, Claire Troakes, Tibor Hortobágyi et al.
Acta neuropathologica communications, Journal article 2019
Journal article

Read the full text
on a web page

2018

No association of salivary total tau concentration with Alzheimer's disease.
Nicholas J. Ashton, Mark Ide, Michael Schöll, Kaj Blennow, Simon Lovestone et al.
Neurobiology of aging, Journal article 2018
Journal article

Read the full text
on a web page

Discriminative Accuracy of F-18 flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
R. Ossenkoppele, G. D. Rabinovici, R. Smith, H. Cho, Michael Schöll et al.
Jama-Journal of the American Medical Association, Journal article 2018
Journal article

Read the full text
on a web page

In vivo Detection of Alzheimer's Disease.
Antoine Leuzy, Kerstin Heurling, Nicholas J. Ashton, Michael Schöll, Eduardo R Zimmer
The Yale journal of biology and medicine, Review article 2018
Review article

Read the full text
on a web page

Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment
Mitzi M Gonzales, Philip S Insel, Craig Nelson, Duygu Tosun, Michael Schöll et al.
International journal of geriatric psychiatry, Journal article 2018
Journal article

Read the full text
on a web page

Update on biomarkers for amyloid pathology in Alzheimer's disease
Nicholas J. Ashton, Michael Schöll, Kerstin Heurling, Eleni Gkanatsiou, Erik Portelius et al.
Biomarkers in medicine, Review article 2018
Review article

Read the full text
on a web page

Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
Michel J Grothe, Jorge Sepulcre, Gabriel Gonzalez-Escamilla, Irina Jelistratova, Michael Schöll et al.
Brain : a journal of neurology, Journal article 2018
Journal article

Read the full text
on a web page

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.
Niklas Mattsson, Oscar Eriksson, Michael Schöll, Björn Lampinen, Markus Nilsson et al.
Neurobiology of aging, Journal article 2018
Journal article

Read the full text
on a web page

18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies.
Ruben Smith, Michael Schöll, Elisabet Londos, Tomas Ohlsson, Oskar Hansson
Scientific Reports, Journal article 2018
Journal article

Read the full text
on a web page

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: A 22-year follow-up study
Steinunn Thordardottir, Elena Rodriguez-Vieitez, Ove Almkvist, Daniel Ferreira, Laure Saint-Aubert et al.
Alzheimer's Research and Therapy, Journal article 2018
Journal article

Read the full text
on a web page

Showing 21 - 30 of 88

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://neurophys.gu.se/english/departments/psychiatry_and_neurochemistry/about-us/staff/?publicationPageNumber=3&selectedTab=2&languageId=100001&disableRedirect=true&returnUrl=http%3A%2F%2Fneurophys.gu.se%2Fsektioner%2Fpsykiatri_och_neurokemi%2Fom-sektionen%2Fpersonal%2F%3Fprint%3Dtrue%26tipFriend%3Dtrue%26tipUrl%3Dhttp%253A%252F%252Fneurophys.gu.se%252Fsektioner%252Fpsykiatri_och_neurokemi%252Fom-sektionen%252Fpersonal%252F%253FpublicationPageNumber%253D4%2526selectedTab%253D2%2526userId%253Dxschom%26publicationPageNumber%3D4%26selectedTab%3D2%26userId%3Dxschom&tipFriend=true&tipUrl=http%3A%2F%2Fneurophys.gu.se%2Fsektioner%2Fpsykiatri_och_neurokemi%2Fom-sektionen%2Fpersonal%2F%3FpublicationPageNumber%3D4%26selectedTab%3D2%26userId%3Dxschom&userId=xschom
Utskriftsdatum: 2020-07-08